Abstract:A CRISPR‐Cas12a‐based dual‐mode assay strategy is developed for multiplexed nucleic acid detection by incorporating precise querying and approximate pattern matching. With the assay, HPV16 and HPV18 are not only distinguished but also 12 other high‐risk pooled HPV subtypes are detected. The assay into a paper‐based microfluidic chip is integrated and its clinical utility with 75 clinical samples, demonstrating significant promise for simple, sensitive, specific, and multiplexed detection of pathogens at the point of care is validated. CRISPR‐Cas12a works like a sophisticated algorithm in nucleic acid detection, yet its challenge lies in sometimes failing to distinguish targets with mismatches due to its specificity limitations. Here, the mismatch profiles, including the quantity, location, and type of mismatches in the CRISPR‐Cas12a reaction, are investigated and its various tolerances to mismatches are discovered. By harnessing the specificity defect of the CRISPR‐Cas12a enzyme, a dual‐mode detection strategy is designed, which includes approximate matching and precise querying of target sequences and develop a programmable multiplexed nucleic acid assay. With the assay, 14 high‐risk human papillomavirus (HPV) subtypes are simultaneously detected, collectively responsible for 99% of cervical cancer cases, with attomolar sensitivity. Specifically, the assay not only distinguishes HPV16 and HPV18, the two most common subtypes but also detects 12 other high‐risk pooled HPV subtypes. To enable low‐cost point‐of‐care testing, the assay is incorporated into a paper‐based microfluidic chip. Furthermore, the clinical performance of the paper‐based microfluidic chip is validated by testing 75 clinical swab samples, achieving performance comparable to that of PCR. This programmable multiplexed nucleic acid assay has the potential to be widely applied for sensitive, specific, and simultaneous detection of different pathogens.

Multiplexed CRISPR/Cas9 quantifications based on bioinspired photonic barcodes

Multiplexed Detection of Tumor Biomarkers Utilizing Immunohybridization Chain Reaction Integrated Photonic Barcodes

DNA Tetrahedron-Based CRISPR Bioassay for Treble-Self-amplified and Multiplex HPV-DNA Detection with Elemental Tagging.

Porous Hydrogel Encapsulated Photonic Barcodes for Multiplex MicroRNA Quantification

Bioinspired Photonic Barcodes for Multiplexed Target Cycling and Hybridization Chain Reaction.

Multiplexed CRISPR-Based Nucleic Acid Detection Using a Single Cas Protein

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Photonic Barcodes Combining Branched Hybridization Chain Reaction for Multiplex Quantification of Bladder Cancer MicroRNAs

CRISPR/Cas12a‐Enabled Multiplex Biosensing Strategy Via an Affordable and Visual Nylon Membrane Readout

Multiplexed Detection Strategies for Biosensors Based on the CRISPR-Cas System

Programmable Multiplexed Nucleic Acid Detection by Harnessing Specificity Defect of CRISPR‐Cas12a

Multiplexed Detection Strategy for Bladder Cancer MicroRNAs Based on Photonic Crystal Barcodes.

Ultrafast Visual Nucleic Acid Detection with CRISPR/Cas12a and Rapid PCR in Single Capillary

CRISPR/Cas12a Powered DNA Framework‐Supported Electrochemical Biosensing Platform for Ultrasensitive Nucleic Acid Analysis

Responsive Photonic Barcodes for Sensitive Multiplex Bioassay.

CRISPR‐Enhanced Hydrogel Microparticles for Multiplexed Detection of Nucleic Acids

CRISPR/Cas Multiplexed Biosensing: A Challenge or an Insurmountable Obstacle?

Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification

Bioinspired Photonic Barcodes: Bioinspired Photonic Barcodes with Graphene Oxide Encapsulation for Multiplexed MicroRNA Quantification (small 52/2018)

CRISPR-associated "genetic scissors" for multiplexing analysis

Universal and high-fidelity DNA single nucleotide polymorphism detection based on a CRISPR/Cas12a biochip